A citation-based method for searching scientific literature

Amy C Degnim, Daniel W Visscher, Hal K Berman, Marlene H Frost, Thomas A Sellers, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, Piet C de Groen, Wilma L Lingle, Karthik Ghosh, Lois Penheiter, Thea Tlsty, L Joseph Melton, Carol A Reynolds, Lynn C Hartmann. J Clin Oncol 2007
Times Cited: 154







List of co-cited articles
684 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Benign breast disease and the risk of breast cancer.
Lynn C Hartmann, Thomas A Sellers, Marlene H Frost, Wilma L Lingle, Amy C Degnim, Karthik Ghosh, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, David W Hillman,[...]. N Engl J Med 2005
518
41


Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
Lynn C Hartmann, Derek C Radisky, Marlene H Frost, Richard J Santen, Robert A Vierkant, Lorelle L Benetti, Yaman Tarabishy, Karthik Ghosh, Daniel W Visscher, Amy C Degnim. Cancer Prev Res (Phila) 2014
110
33

Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
D L Page, W D Dupont, L W Rogers, M S Rados. Cancer 1985
741
29

Atypical hyperplasia of the breast--risk assessment and management options.
Lynn C Hartmann, Amy C Degnim, Richard J Santen, William D Dupont, Karthik Ghosh. N Engl J Med 2015
165
28

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.
Suzanne B Coopey, Emanuele Mazzola, Julliette M Buckley, John Sharko, Ahmet K Belli, Elizabeth M H Kim, Fernanda Polubriaginof, Giovanni Parmigiani, Judy E Garber, Barbara L Smith,[...]. Breast Cancer Res Treat 2012
75
33

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005
854
23

Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.
Laura C Collins, Heather J Baer, Rulla M Tamimi, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2007
92
25

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011
580
23

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
21

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.
David L Page, Peggy A Schuyler, William D Dupont, Roy A Jensen, W Dale Plummer, Jean F Simpson. Lancet 2003
199
20

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
353
19

Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
Lee J McGhan, Barbara A Pockaj, Nabil Wasif, Marina E Giurescu, Ann E McCullough, Richard J Gray. Ann Surg Oncol 2012
60
28

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
16

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
398
15

Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
Miraj G Shah-Khan, Xochiquetzal J Geiger, Carol Reynolds, James W Jakub, Elizabeth R Deperi, Katrina N Glazebrook. Ann Surg Oncol 2012
63
22

The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Laura C Collins, Heather J Baer, Rulla M Tamimi, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2006
48
29

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
Judy C Boughey, Lynn C Hartmann, Stephanie S Anderson, Amy C Degnim, Robert A Vierkant, Carol A Reynolds, Marlene H Frost, V Shane Pankratz. J Clin Oncol 2010
76
17

Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.
Melissa P Murray, Chad Luedtke, Laura Liberman, Tatjana Nehhozina, Muzaffar Akram, Edi Brogi. Cancer 2013
79
16

Gene expression profiles of human breast cancer progression.
Xiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, Justin Gaudet, Edward Enright, Philip McQuary, Terry Payette, Maria Pistone, Kimberly Stecker, Brian M Zhang,[...]. Proc Natl Acad Sci U S A 2003
626
13

Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision.
Christopher V Nguyen, Constance T Albarracin, Gary J Whitman, Adriana Lopez, Nour Sneige. Ann Surg Oncol 2011
65
20

A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
Geoffrey C Kabat, Joan G Jones, Neal Olson, Abdissa Negassa, Catherine Duggan, Mindy Ginsberg, Rita A Kandel, Andrew G Glass, Thomas E Rohan. Cancer Causes Control 2010
62
19

A prospective study of benign breast disease and the risk of breast cancer.
S J London, J L Connolly, S J Schnitt, G A Colditz. JAMA 1992
354
12

Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications.
Jennifer R Kohr, Peter R Eby, Kimberly H Allison, Wendy B DeMartini, Robert L Gutierrez, Sue Peacock, Constance D Lehman. Radiology 2010
72
16


Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
Mara H Rendi, Suzanne M Dintzis, Constance D Lehman, Kristine E Calhoun, Kimberly H Allison. Ann Surg Oncol 2012
79
15


Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
11

Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients.
Caroline Forgeard, Medhi Benchaib, Nicole Guerin, Philippe Thiesse, Hervé Mignotte, Christelle Faure, Catherine Clement-Chassagne, Isabelle Treilleux. Am J Surg 2008
68
16

The molecular pathology of breast cancer progression.
Alessandro Bombonati, Dennis C Sgroi. J Pathol 2011
223
10

Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
L M Marshall, D J Hunter, J L Connolly, S J Schnitt, C Byrne, S J London, G A Colditz. Cancer Epidemiol Biomarkers Prev 1997
161
10

Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade.
Kimberly H Allison, Peter R Eby, Jennifer Kohr, Wendy B DeMartini, Constance D Lehman. Hum Pathol 2011
42
23

Assessment of the accuracy of the Gail model in women with atypical hyperplasia.
V Shane Pankratz, Lynn C Hartmann, Amy C Degnim, Robert A Vierkant, Karthik Ghosh, Celine M Vachon, Marlene H Frost, Shaun D Maloney, Carol Reynolds, Judy C Boughey. J Clin Oncol 2008
65
15

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
699
10

Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Isabelle Deshaies, Louise Provencher, Simon Jacob, Gary Côté, Jean Robert, Christine Desbiens, Brigitte Poirier, Jean-Charles Hogue, Eric Vachon, Caroline Diorio. Breast 2011
45
22

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Paul J Chuba, Merlin R Hamre, Johnny Yap, Richard K Severson, David Lucas, Falah Shamsa, Amr Aref. J Clin Oncol 2005
146
10

Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years.
P P Rosen, C Kosloff, P H Lieberman, F Adair, D W Braun. Am J Surg Pathol 1978
324
10


Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.
Laura C Collins, Sarah A Aroner, James L Connolly, Graham A Colditz, Stuart J Schnitt, Rulla M Tamimi. Cancer 2016
33
30

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.
Amy C Degnim, William D Dupont, Derek C Radisky, Robert A Vierkant, Ryan D Frank, Marlene H Frost, Stacey J Winham, Melinda E Sanders, Jeffrey R Smith, David L Page,[...]. Cancer 2016
30
33

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
Alvaro Peña, Sejal S Shah, Robert T Fazzio, Tanya L Hoskin, Rushin D Brahmbhatt, Tina J Hieken, James W Jakub, Judy C Boughey, Daniel W Visscher, Amy C Degnim. Breast Cancer Res Treat 2017
38
26



Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
Eunyoung Ko, Wonshik Han, Jong Won Lee, Jihyoung Cho, Eun-Kyu Kim, So-Youn Jung, Mee Joo Kang, Woo Kyung Moon, In Ae Park, Sung-Won Kim,[...]. Breast Cancer Res Treat 2008
52
17

Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.
Tehillah S Menes, Robert Rosenberg, Steven Balch, Shabnam Jaffer, Karla Kerlikowske, Diana L Miglioretti. Am J Surg 2014
48
18


Current management of lesions associated with an increased risk of breast cancer.
Monica Morrow, Stuart J Schnitt, Larry Norton. Nat Rev Clin Oncol 2015
64
14

Age-related lobular involution and risk of breast cancer.
Tia R Milanese, Lynn C Hartmann, Thomas A Sellers, Marlene H Frost, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, Amy C Degnim, Celine M Vachon, Carol A Reynolds,[...]. J Natl Cancer Inst 2006
176
8

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.
C L Carter, D K Corle, M S Micozzi, A Schatzkin, P R Taylor. Am J Epidemiol 1988
269
8

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015
247
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.